経橈骨動脈アクセスデバイスの世界市場：2023年～2030年

市場概要

経橈骨動脈アクセスデバイスの世界市場は、2022年に20億米ドルに達し、2023-2030年の予測期間中にCAGR 7.4%で成長し、2030年には34億米ドルに達すると予測されています。

経橈骨手技は、冠動脈および末梢血管造影やインターベンションを行うための実用的で低侵襲なアプローチです。経橈骨動脈カテーテル治療は一般的に、より安全で費用対効果が高く、患者に優しい治療法です。

市場力学

老年人口の増加が市場成長の原動力

経橈骨動脈アクセスデバイス市場を押し上げる主な原動力の一つは、高齢者人口の拡大です。高齢者人口のかなりの割合が心臓発作を患い、心臓血管外科手術を受けています。これらの疾患の中でも、うっ血性心不全、冠動脈疾患、高血圧、心房細動が最も重要です。

例えば、AHAジャーナルによると、60歳以上の高齢者の55％から98％が少なくとも2つの慢性疾患を有していると推定されています。このように、高齢者人口の増加が市場成長の原動力となっています。

心血管疾患罹患率の増加が市場成長を牽引

末梢血管疾患などの慢性疾患の罹患率の増加が市場成長を促進します。心血管疾患は頻繁に発生する疾患です。脳卒中、末梢動脈疾患、大動脈疾患などが頻繁に発生します。例えば、ニューヨーク政府によると、毎年約80万5千人のアメリカ人が心臓発作を起こしています。したがって、心血管疾患の発生率の増加は市場の成長を拡大すると思われます。

機器に伴う副作用が市場成長を妨げる

経橈骨動脈アクセスデバイスに関連する副作用は市場成長の低下を引き起こす可能性があります。経橈骨動脈アクセスデバイスの使用に起因する副作用は数多く存在します。そのため

血管合併症を引き起こす可能性があります。例えば、経橈骨アクセス後の合併症で最も頻度の高いものは、橈骨動脈閉塞の約5％のリスクです。

Allenテストが標準的であれば、これは臨床的に重要でない合併症です。掌側弓が不完全でAllenテストに異常のある患者は、橈骨動脈閉塞後に手の虚血の症状を示すことがあります。このように、関連する副作用は市場の成長を妨げる可能性があります。

COVID-19影響分析

COVID-19の流行は経橈骨動脈アクセスデバイス市場に大きな影響を与え、多くの国に前例のない課題をもたらしています。心血管系疾患に関連する治療手順の遅延や手術の延期は、経橈骨動脈アクセスデバイスの使用に影響を示しています。その結果、経橈骨動脈アクセスデバイス市場の成長は著しく低下しました。

目次

第1章 調査手法と調査範囲

第2章 定義と概要

第3章 エグゼクティブサマリー

第4章 市場力学

• 影響要因
  • 促進要因
    • 冠動脈手術件数の増加
    • 世界中の人々の意識の高まり
  • 抑制要因
    • 機器に伴う合併症
  • 機会
    • 継続的な研究開発とトレーニングの取り組み
  • 影響分析

第5章 産業分析

• ポーターの5フォース分析
• サプライチェーン分析
• 価格分析
• 規制分析

第6章 COVID-19分析

第7章 ロシア・ウクライナ影響分析

第8章 製品タイプ別

• カテーテル
• ガイドワイヤー
• シース
• その他

第9章 用途別

• 薬剤投与
• 輸血
• 診断
• その他

第10章 エンドユーザー別

• 病院
• 専門クリニック
• 外来手術センター
• その他

第11章 地域別

• 北米
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • ドイツ
  • 英国
  • フランス
  • スペイン
  • イタリア
  • その他欧州
• 南米
  • ブラジル
  • アルゼンチン
  • その他南米
• アジア太平洋
  • 中国
  • インド
  • 日本
  • オーストラリア
  • その他アジア太平洋地域
• 中東・アフリカ

第12章 競合情勢

• 競合シナリオ
• 市況/シェア分析
• M&A分析

第13章 企業プロファイル

• Ameco Medical
  • 会社概要
  • 製品ポートフォリオと説明
  • 財務概要
  • 主な発展
• BD
• Angiodynamics, Inc.
• Boston Scientific Corporation
• Edward Lifesciences Corporation
• Teleflex Incorporated
• Merit Medical Systems
• Medtronic
• Nipro Medical Corporation
• Oscor Inc.

第14章 付録

Market Overview

Global Transradial Access Device Market reached US$ 2.0 billion in 2022 and is expected to reach US$ 3.4 billion by 2030 growing with a CAGR of 7.4% during the forecast period 2023-2030.

The transradial technique is a practical, minimally invasive approach to performing coronary and peripheral angiograms and interventions. Transradial catheterization is typically a safer, more cost-effective, and patient-friendly procedure.

Market Dynamics

Growing Geriatric Population will Drive the Growth of the Market

One of the primary driving factors that would boost the tranradial access device market is the expanding older population. A considerable proportion of the elderly population suffers from heart strokes and undergoes cardiovascular surgeries. Among these diseases, congestive heart failure, coronary artery diseases, hypertension, and atrial fibrillation have the greatest significance.

For instance, according to AHA Journals, it has been estimated that between 55% and 98% of older adults aged 60 years and over have at least 2 chronic diseases. Thus, increase in the population of older people is driving the market growth.

Increase in the Incidence of Cardiovascular Diseases is Driving the Market Growth

Increased disease incidences of chronic diseases, such as peripheral vascular diseases, will fuel market growth. Cardiovascular diseases are frequently occurring diseases. Stroke, peripheral arterial disease, and aortic disease events frequently occur. For instance, according to New York Govt., every year, about 805,000 Americans have a heart attack. Thus increase in the incidence of cardiovascular diseases will expand the market growth.

Side Effects Associated with the Devices Will Hamper the Market Growth

The side effects associated with transradial access devices can cause a decline in market growth. There are a number of side effects that are resulted due to the use of transradial access devices. The

use of transradial devices can lead to vascular complications. For instance, the most frequent complication after transradial access is about a 5% risk of radial artery occlusion.

This is a clinically insignificant complication if the Allen test is standard. Patients with incomplete palmar arch and abnormal Allen test may have symptoms of hand ischemia after radial artery occlusion. Thus, the side effects associated can hamper the market growth.

COVID-19 Impact Analysis

The COVID-19 pandemic epidemic has had a significant influence on the transradial access device market, posing unprecedented challenges to many countries. Delay in the treatment procedure and postponement of surgeries related to cardiovascular diseases has shown the impact on using the transradial access device. This resulted in a significant decline in the transradial device market growth.

Segment Analysis

The transradial access device market is segmented based on product type, application, and end user.

The Guidewires Segment Accounts for 27.3% the of Transradial Access Device Market Share

Guidewires are used during minimally invasive interventional procedures to traverse in the vascular system and access the desired position. Computer models are increasingly being used to predict the behavior of these instruments. Ace Angiography Guide Wires are hydrophilic guidewires and are used for percutaneous vessel entry to facilitate the subsequent introduction of an intravascular device. This device is supplied sterile in a peel-open pouch.

The purpose of a guidewire is to gain access to the blood vessels using a minimally invasive technique. For instance, according to CDC, coronary heart disease is the most common type of heart disease, killing 375,476 people in 2021. Thus, an increase in the number of coronary heart diseases expands the market growth. Thus, the cardiovascular disease segment holds the leading position in the market share.

Geographical Analysis

Asia Pacific accounted for Approximately 23.4% of the Market Share Owing to the Increasing Geriatric Population.

During the forecast period, Asia-Pacific is expected to grow at the fastest rate because of the growing geriatric population in nations such as India and China, the region has become a hotspot for cardiovascular disorders, increasing demand for coronary therapies and fueling company expansion. As well as an increase in the number of cases of cardiovascular disease and technical advancement in this region.

For instance, according to NLM, India has one of the world's highest burdens of cardiovascular disease (CVD). The annual number of CVD fatalities in India is expected to climb from 2.26 million in 1990 to 4.77 million in 2020. Over the last several decades, estimates of the prevalence of coronary heart disease in India have ranged from 1.6% to 7.4% in rural populations and from 1% to 13.2% in urban populations. As a result, diseases are on the rise, which contributes to the region's growth.

Competitive Landscape

The major global players in the transradial access device market include: AmecoMedical; BD; Angiodynamics, Inc.; BostonScientific Corporation; Edward Lifesciences Corporation; Teleflex Incorporated; Merit Medical Systems; Medtronic; Nipro Medical Corporation; Oscor Inc. among others.

Why Purchase the Report?

• To visualize the transradial access device market segmentation based on product type, application, end-user, and region, as well as understand key commercial assets and players.
• Identify commercial opportunities by analyzing trends and co-development.
• Excel data sheet with numerous data points of transradial access device market-level with all segments.
• PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.
• Product mapping available as Excel consisting of key products of all the major players.

The transradial access device market report would provide approximately 53 tables, 54 figures, and 195 Pages.

Target Audience 2023

• Manufacturers/ Buyers
• Industry Investors/Investment Bankers
• Research Professionals
• Emerging Companies

Table of Contents

1. Methodology and Scope

• 1.1. Research Methodology
• 1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

• 3.1. Snippet by Product Type
• 3.2. Snippet by Application
• 3.3. Snippet by End User
• 3.4. Snippet by Region

4. Dynamics

• 4.1. Impacting Factors
  • 4.1.1. Drivers
    • 4.1.1.1. Rise in the number of coronary artery procedures
    • 4.1.1.2. Increasing awareness among people around the world
  • 4.1.2. Restraints
    • 4.1.2.1. Complications Associated with the Devices
  • 4.1.3. Opportunity
    • 4.1.3.1. Continued research and developments and training initiatives
  • 4.1.4. Impact Analysis

5. Industry Analysis

• 5.1. Porter's 5 Forces Analysis
• 5.2. Supply Chain Analysis
• 5.3. Pricing Analysis
• 5.4. Regulatory Analysis

6. COVID-19 Analysis

• 6.1. Analysis of COVID-19
  • 6.1.1. Scenario Before COVID-19
  • 6.1.2. Scenario During COVID-19
  • 6.1.3. Scenario Post COVID-19
• 6.2. Pricing Dynamics Amid COVID-19
• 6.3. Demand-Supply Spectrum
• 6.4. Government Initiatives Related to the Market During the Pandemic
• 6.5. Manufacturers' Strategic Initiatives
• 6.6. Conclusion

7. Russia-Ukraine Impact Analysis

8. By Product Type

• 8.1. Introduction
  • 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 8.1.2. Market Attractiveness Index, By Product Type
• 8.2. Catheters
  • 8.2.1. Introduction
  • 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 8.3. Guidewires
• 8.4. Sheaths
• 8.5. Others

9. By Application

• 9.1. Introduction
  • 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 9.1.2. Market Attractiveness Index, By Application
• 9.2. Drug Administration
  • 9.2.1. Introduction
  • 9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 9.3. Blood Transfusion
• 9.4. Diagnostics
• 9.5. Others

10. By End User

• 10.1. Introduction
  • 10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 10.1.2. Market Attractiveness Index, By End User
• 10.2. Hospitals
  • 10.2.1. Introduction
  • 10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
• 10.3. Specialty clinics
• 10.4. Ambulatory surgical centers
• 10.5. Others

11. By Region

• 11.1. Introduction
  • 11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
  • 11.1.2. Market Attractiveness Index, By Region
• 11.2. North America
  • 11.2.1. Introduction
  • 11.2.2. Key Region-Specific Dynamics
  • 11.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.2.6.1. U.S.
    • 11.2.6.2. Canada
    • 11.2.6.3. Mexico
• 11.3. Europe
  • 11.3.1. Introduction
  • 11.3.2. Key Region-Specific Dynamics
  • 11.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.3.6.1. Germany
    • 11.3.6.2. U.K.
    • 11.3.6.3. France
    • 11.3.6.4. Spain
    • 11.3.6.5. Italy
    • 11.3.6.6. Rest of Europe
• 11.4. South America
  • 11.4.1. Introduction
  • 11.4.2. Key Region-Specific Dynamics
  • 11.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.4.6.1. Brazil
    • 11.4.6.2. Argentina
    • 11.4.6.3. Rest of South America
• 11.5. Asia-Pacific
  • 11.5.1. Introduction
  • 11.5.2. Key Region-Specific Dynamics
  • 11.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
  • 11.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
    • 11.5.6.1. China
    • 11.5.6.2. India
    • 11.5.6.3. Japan
    • 11.5.6.4. Australia
    • 11.5.6.5. Rest of Asia-Pacific
• 11.6. Middle East and Africa
  • 11.6.1. Introduction
  • 11.6.2. Key Region-Specific Dynamics
  • 11.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product Type
  • 11.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
  • 11.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User

12. Competitive Landscape

• 12.1. Competitive Scenario
• 12.2. Market Positioning/Share Analysis
• 12.3. Mergers and Acquisitions Analysis

13. Company Profiles

• 13.1. Ameco Medical
  • 13.1.1. Company Overview
  • 13.1.2. Product Portfolio and Description
  • 13.1.3. Financial Overview
  • 13.1.4. Key Developments
• 13.2. BD
• 13.3. Angiodynamics, Inc.
• 13.4. Boston Scientific Corporation
• 13.5. Edward Lifesciences Corporation
• 13.6. Teleflex Incorporated
• 13.7. Merit Medical Systems
• 13.8. Medtronic
• 13.9. Nipro Medical Corporation
• 13.10. Oscor Inc.

LIST NOT EXHAUSTIVE

14. Appendix

• 14.1. About Us and Services
• 14.2. Contact Us